Education
About Us
Working with TipRanks
Follow Us
Vivoryon Therapeutics AG (DE:05Y)
FRANKFURT:05Y
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | € -3.62M | € 0.00 | € 10.76M | € 0.00 | € 0.00 |
| Gross Profit | € -3.10M | € -161.00K | € 9.03M | € -146.00K | € -88.00K |
| Operating Income | € -28.84M | € -29.13M | € -12.81M | € -16.02M | € -7.77M |
| EBITDA | € -28.35M | € -28.17M | € -12.03M | € -16.34M | € -7.63M |
| Net Income | € -28.34M | € -28.16M | € -12.65M | € -16.51M | € -7.82M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | € 28.58M | € 26.55M | € 14.66M | € 26.31M | € 41.52M |
| Total Assets | € 30.83M | € 31.38M | € 24.52M | € 29.75M | € 45.86M |
| Total Debt | € 38.00K | € 132.00K | € 224.00K | € 314.00K | € 406.00K |
| Net Debt | € -18.52M | € -26.42M | € -14.44M | € -25.99M | € -41.12M |
| Total Liabilities | € 4.55M | € 4.87M | € 7.96M | € 3.53M | € 3.20M |
| Stockholders' Equity | € 26.28M | € 26.51M | € 16.56M | € 26.22M | € 42.66M |
| Cash Flow | |||||
| Free Cash Flow | € -22.05M | € -21.81M | € -11.29M | € -14.65M | € -11.65M |
| Operating Cash Flow | € -21.54M | € -21.79M | € -11.26M | € -14.01M | € -11.61M |
| Investing Cash Flow | € -10.51M | € -13.00K | € -28.00K | € -640.00K | € -47.00K |
| Financing Cash Flow | € 24.16M | € 33.38M | € -827.00K | € -90.00K | € 49.35M |
Vivoryon Therapeutics AG Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.